Repeal and Replace May Have Failed Anyway

Pundits have posited every imaginable reason for the failure of the GOP to get their health care reform bill through the first big hurdle: passage on the House floor. As we all know too well, Speaker Ryan pulled the bill just minutes before a vote was scheduled, when it was absolutely clear that a majority of support could not be reached. But would success have ushered in a new health care paradigm? I doubt it.

Trump and House Tax Plans Have One Thing in Common: They Likely Hit Nonprofits Hard

“If the tax incentive [for charitable giving] goes away, people will still undoubtedly give to charity, said Alex Brill, research fellow at AEI who published the findings. The AEI model accounts for it. But gifts from wealthy donors could decrease significantly. ‘There’s consensus that the tax break definitely matters. People are always going to quibble about the exact magnitude of the impact,’ Brill said, citing end-of-the-year giving as one example.

‘Ambitious’ and ‘Aggressive’ Timing for Mnuchin’s Tax Plan May Not Play Out, Experts Say

“The Trump administration could face some trouble getting its tax reform through by August, [said] Alex Brill…. ‘There’s only so much that Congress can process at the same time. I was very pleased to hear [Treasury Secretary Mnuchin] put an emphasis and a priority on tax reform, an aggressive schedule of a bill signing in August, but we do need to recognize that there’s a whole other conversation in Washington about [Affordable Care Act] repeal, repeal and replace, or repeal and repair that is potentially in conflict,’ simply due to time constraints, Brill said.”

MGA’s Alex Brill on CNBC’s Squawk Box

“Tax reform is by definition a game about winners and losers. If there aren’t winners and losers, it’s not tax reform. So there should be no surprise that there are people who are upset about the things that are being discussed, but that doesn’t make it a bad idea…. The idea…is to create a level playing field. There are winners and losers today as a result of the tax code, and if we can clean that system up, we can create fairness between debt and equity, between corporate and non-corporate, between domestically domiciled corporations and foreign competitors.”

Border Adjustment Tax: $260 Billion More Than You Thought

If the House Republican plan for a border adjustment tax were adopted, many large U.S. multinationals and others net exporters would receive more tax subsidy on their exports than tax owed on their other business activities. Without refundable credits, a 20% border adjustment tax would actually yield $260 billion in revenue beyond the expected $1 trillion.

MGA’s Alex Brill Serves as a Panelist at Opportunity America’s “This Way Up: Economic Mobility for Poor and Middle-Class Americans”

At an event on conservative policies for helping poor and middle-class Americans, Alex Brill discussed how best to promote upward mobility: “I think that in the long run, if we provide some relief or assistance to those workers and those families without the kind of structural reforms that Speaker Ryan was talking about — closing the skills gap and things like that — then what are we going to do ten years from now when those people aren’t moving up through the system?”

Trump Tax Plan Could Negatively Impact Giving

President Trump’s proposal to cap itemized deductions would cause a drop in charitable giving. For those giving above the cap, the net cost would jump from $0.60 per $1 of giving to an unsubsidized $1 per $1 of giving. Because a 1% increase in the price yields a 1% drop in giving, $17.6 billion in annual giving could evaporate.

MGA’s Alex Brill Serves as a Panelist at the National Coalition on Health Care’s Capitol Hill Forum

From the Coalition to Protect Patient Choice:

“The last panelist was Alex Brill… [who] spoke about FDA reform and specifically about patent issues relating to biologic drugs and their generic counterparts known as biosimilars. He stated that biosimilar entry has not been as robust as was envisioned by the Affordable Care Act, due to archaic regulatory schemes, anticompetitive conduct, and cost-benefit analysis.”